EQUINE protozoal myeloencephalitis (EPM) is a progressive neurological disease of horses caused by infection of the central nervous system (CNS) with the apicomplexan parasites Sarcocystis neurona or Neospora hughesi (Mayhew and others 1976 , Marsh and others 1996 , Dubey and others 2001a . Because these protozoa may infect any part of the CNS, affected horses may show a range of neurological deficits and a definitive diagnosis of EPM is not possible by clinical signs alone; furthermore, no consistent abnormalities are observed in the cerebrospinal fluid (CSF) (Johnson and Constantinescu 2001) . An important advance in the antemortem diagnosis of EPM was the development of an immunoblot assay for the detection of antibodies to S neurona in serum and CSF (Granstrom and others 1993) , but more recently it has been shown that a quantitative indirect fluorescent antibody test is more useful than the immunoblot assay for predicting the likelihood of infection (Duarte and others 2003) .
The immune response of horses to infection with apicomplexan parasites is poorly understood. Studies of related apicomplexan protozoa, such as Toxoplasma gondii, have shown that cell-mediated immune responses are essential for the host to control intracellular infections (Denkers and Gazzinelli 1998) , and similar immune mechanisms are probably involved with S neurona and N hughesi. Sellon and others (2002) showed that Arabian horses with severe combined immune deficiency, an inherited disease characterised by a lack of specific B and T cell responses, were more susceptible to EPM than immune-competent horses, suggesting that both specific and non-specific immunity may be necessary for the control of protozoal infections and the prevention of neuroinvasion. In recent years, it has become evident that cell-and antibody-mediated immune responses must be tightly regulated for the optimal control of infection and that cytokine imbalances resulting from a loss of control can play a role in the pathological changes associated with intracellular organisms (Denkers and Gazzinelli 1998) . However, the mechanism of neuropathogenesis associated with EPM is not fully understood; few organisms are usually visible in neural tissues of affected horses, even when there are extensive histological lesions, suggesting that cytokines and/or metabolites may be important contributors to the pathological changes.
Equine herpesvirus type 1 (EHV-1) myeloencephalop athy is an uncommon manifestation of EHV-1 infection but can cause devastating losses during outbreaks on individual farms or boarding stables (McCartan and others 1995) . Its clinical signs indicate a diffuse multifocal myeloencephalopathy as a result of vasculitis, haemorrhage, thrombosis and ischaemic neuronal injury. It is often not possible to confirm a diagnosis of EHV-1 myeloencephalopathy antemortem, particularly when only one horse is affected, because diagnostic tests do not yield consistent results. The pathogenesis of EHV-1 myeloencephalopathy is by no means certain; the vascular endothelium is a secondary site of viral replication (Jackson and others 1977, Edington and others 1991) and the vasculitis may be the result of two mechanisms, first, direct damage to the endothelial cells lining small blood vessels, and secondly, the formation and deposit of immune complexes of EHV-1 virus and antibody, an Arthrus-type reaction.
There is no information about the production of cytokines in neural tissue of horses naturally infected with S neurona, N hughesi or EHV-1, and it is not known how the cytokine profiles in the neural tissues of horses with EPM and EHV-1 myeloencephalopathy compare with those of horses with no clinical evidence of neurological diseases. The purpose of this study was to compare the expression of cytokines in the brain and spinal cord of horses with EPM with their expression in horses with EHV-1 myeloencephalopathy and in healthy control horses.
MATERIALS AND METHODS

Case selection and tissue samples
The study material consisted of formalin-fixed brain or spinal cord. The first group of tissues came from 12 horses with EPM, six of which had been used in an earlier study to validate an EPM Western blot (Daft and others 2002) . They were selected on the basis of having histological lesions of perivascular lymphocytic cuffing and inflammation of neuropil compatible with S neurona or N hughesi infection, and the demonstration of parasite antigen within the lesions by immunostaining (Dubey and others 2001b) . The second group of tissues came from 11 horses with histological lesions of encephalomalacia with haemorrhage, vascular thrombosis and perivascular mononuclear cell cuffing compatible with EHV-1 infection, which was confirmed by the detection of EHV-1 in the lesions by immunoperoxidase staining (Schultheiss and others 1997) . The third group of tissues came from 12 healthy horses, 10 of which had been used as EPM-negative control horses in a study by Daft and others (2002) ; they had been euthanased or died as a result of musculoskeletal injuries sustained during racing or training, or because of an irreversible condition, such as pleuropneumonia, colitis, laminitis or chronic musculoskeletal disease. These horses had shown no neurological signs, had no detectable S neurona antibodies in serum or CSF by Western blot, and had no histological abnormalities on routine sections of brain or spinal cord.
Pathogen detection
Two quantitative real-time TaqMan (Applied Biosystems) PCR assays for the detection of the apicomplexan protozoa S neurona and N hughesi were designed and optimised. The genes for the 18S ribosomal RNA of S neurona (GenBank accession number U07812) and the internal transcribed spacer region 1 (ITS-1) (sequence between 18S and 5·8S rRNA genes) of N hughesi (AF038859) were selected as target genes. Multiple sequence alignments, using sequences deposited in GenBank, were used to identify a sequence in the 5ʹ region of the 18S rRNA gene for the S neurona TaqMan PCR system that made it possible to distinguish it from N hughesi and other closely related organisms. In addition, 18S rRNA sequences for Cryptosporidium parvum (AF093489), Isospora suis (U97523) and T gondii (U17349) were included to ensure the specificity of the S neurona PCR system. The same method was used to select a sequence in the ITS-1 of N hughesi and its specificity was tested by using genomic DNA extracted from ATCC strains or characterised field isolates of T gondii (RH1 and ME49 strains), S neurona (horse isolate), S neurona (harbour seal isolate), S neurona (California sea otter isolate), Sarcocystis falcatula (opossum isolate), Neospora caninum (cattle isolate), N hughesi (horse isolate) and C parvum (cattle isolate). Analytical sensitivity was assessed indirectly by determining the amplification efficiency as a marker for the efficiency of amplification of the PCR product.
Similarly, a quantitative real-time TaqMan PCR assay for the detection and quantitation of EHV-1 glycoprotein B (gB) gene was established and validated. The EHV-1 gB assay was based on the detection of a specific product of the gB gene of EHV-1 (NC001491). Its specificity was tested by using genomic DNA extracted from ATCC strains or characterised field isolates of EHV-1, EHV-4, EHV-2, EHV-5, equine influenza virus and equine viral arteritis virus. The three PCR systems were designed using Primer Express 1.5 software (Applied Biosystems). The specificity of the PCR products was tested using the BLAST function on the National Center for Biotechnology Information (NCBI) website and by sequencing the PCR products from positive PCR reactions.
RNA extraction, cDNA synthesis and quantitation of antigen and cytokine transcript Total RNA was extracted from 50 µm sections of formalinfixed, paraffin-embedded brain or spinal cord after the paraffin had been removed with xylene in 70 per cent ethanol. The sample was resuspended in lysis buffer (DNeasy Tissue Kit; Qiagen) and incubated with proteinase K at 56°C for 14 hours. Nucleic acids were extracted according to the manufacturer's directions and eluted in PCR-grade water. The nucleic acid was digested with RNase-free DNase I (Promega) at 37°C for 40 minutes, followed by five minutes at 95°C, and then chilled on ice.
Reverse transcription reactions were carried out with 20 µl of total RNA preincubated with 600 ng random hexadeoxyribonucleotide (pd[N]6) primers (random hexamers; Promega), in a final volume of 40 µl containing 50mM TrisHCl (pH 8·3), 50mM potassium chloride, 8mM magnesium chloride, 0·5mM dNTPs, 40 U RNase inhibitor (Invitrogen), 0·5mM dithiothreitol (DTT) and 100 U SuperScript III (Invitrogen) at 50°C for 120 minutes. After inactivation at 95°C for five minutes, the reaction volume was adjusted to 100 µl with nuclease-free water. The cDNA was either analysed immediately or stored at -20°C for analysis later.
Real-time TaqMan PCR systems for equine GAPDH (housekeeping gene), tumour necrosis factor (TNF)-α, interferon (IFN)-γ, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10 and IL-12 p40 have been described by Leutenegger and others (1999b) and Colahan and others (2002) . The PCR reactions contained 400nM of each primer, 80nM of the TaqMan probe and mastermix (TaqMan Universal PCR Mastermix; Applied Biosystems) and 5 µl of the diluted cDNA sample in a final volume of 12 µl. The samples were amplified in a combined thermocycler/fluorometer (ABI PRISM 7700 Sequence Detection System; Applied Biosystems) for two minutes at 50°C, 10 minutes at 95°C, and then 40 cycles of 15 seconds at 95°C and 60 seconds at 60°C. Final quantitation was achieved by using the comparative C T method (Leutenegger and others 1999a) and is reported as relative transcription or the nfold ratio to the weakest signal, that is, the lowest level of cytokine or pathogen transcription in brain or spinal cord. The Mann-Whitney U test was used to determine significant differences (P<0·05) between the cytokine gene expression of the different groups of horses. Correlation coefficients were determined between the transcriptional activity of the pathogens and cytokines.
RESULTS
Specificity and sensitivity of the PCR assays
The two protozoal PCR systems were highly specific for S neurona or N hughesi DNA and did not cross-react with each other or with DNA from T gondii or C parvum. Similarly, the EHV-1 PCR system recognised only EHV-1 and did not crossreact with other closely related equine viral pathogens such as EHV-2, EHV-4 and EHV-5. Amplification efficiencies (E) were obtained on genomic DNA from the field isolates of S neurona, N hughesi and EHV-1 by running standard curves (s) on six 10-fold dilutions of DNA in triplicate; they were calculated from the slope of the standard curve with the formula E = 10 1/-s -1. The efficiency with which the PCR systems amplified the target sequences were 98·0 per cent for S neurona, 99·5 per cent for N hughesi and 99·2 per cent for EHV-1, indicating that there had been a doubling of PCR products with every PCR cycle, and providing strong evidence of good analytical sensitivity (Leutenegger and others 2001) .
Antigen quantitation and cytokine gene signatures S neurona cDNA was detected in the neural tissue of all 12 of the horses with EPM in group 1, and N hughesi cDNA was detected in two of them, but none of them tested positive for EHV-1 cDNA (Fig 1) . The mean (sd) relative level of transcription of S neurona was 123 (154), with a range from 1 to 461 times baseline in the 12 horses. In two of the group 1 horses both S neurona (with cDNA transcription levels of 5·2 and 85·6) and N hughesi (with cDNA transcription levels of 2048 and 1) were detected. All the 11 horses in group 2 had a detectable EHV-1 signal, with a mean (sd) relative level of transcription of 276 (491), and a range from 1 to 1618 times baseline; none of the 11 horses tested positive for the apicomplexan protozoa. All the 12 horses in group 3 tested negative for S neurona, N hughesi and EHV-1 cDNA.
Only GAPDH was found to be expressed constitutively in the 12 control horses from group 3, and the level of GAPDH expression was similar in all three groups of horses, indicating that there were no differences in the efficiency of RNA extraction or level of cDNA transcription. Fig 2 shows in 10 horses (range 1 to 534, mean 120 [194] ) and TNF-α in two (5·1 and 9·6) (Fig 2) , but they did not express IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-10 or IL-12 p40. The gene transcription of IL-8 was significantly higher in the EPM-positive tissues than in the EHV-1-positive tissues (P<0·05). Any down-regulation of cytokine genes could not be assessed for the EPM and EHV-1 positive tissues because the control tissues (group 3) expressed only GAPDH. The relative levels of transcription of protozoal cDNA was directly correlated with the level of IL-8 (R=0·66) and IFN-γ (R=0·52) gene transcription, but there was no such correlation for TNF-α. There was also a direct correlation between the gene transcription of TNF-α and IL-8 (R=0·73) in the horses with EPM, but there was no correlation between the relative levels of transcription of EHV-1 cDNA and Correlations between the transcription levels of protozoal cDNA and IL-10, and between EHV-1 cDNA and TNF-α could not be calculated owing to the small numbers of positive samples.
DISCUSSION
In recent years, it has become clear that Th1 and Th2 cytokine responses must be tightly regulated by the host for the optimal control of infection, and that cytokine imbalances resulting from a loss of control can play a role in the pathological changes associated with infections by intracellular organisms. In this study, in an attempt to improve the understanding of the pathophysiology of EPM and EHV-1 myeloencephalopathy, the relative levels of transcription of the pathogenic cDNA were determined and the gene transcription of selected cytokines was measured in formalin-fixed and paraffin-embedded neural tissue from naturally infected horses.
The use of novel and more sensitive molecular techniques, such as quantitative real-time PCR, has made it possible to measure the pathogens and cytokine transcription with greater analytical specificity and sensitivity. The results show that archived brain tissue is a suitable sample for RNA testing by real-time PCR, and that the test is sensitive and practical for the detection of different pathogens and a variety of cytokine genes. As previously reported, the assay of each sample was normalised to an internal RNA GAPDH control signal to account for the possible loss of signal strength as a result of fixation of the sample in formalin and its embedding in paraffin, its period in storage, and nucleic-acid processing (Foley and others 2003) . In order to investigate the influence of protozoal pathogens and EHV-1 on the brain and spinal cord, only tissue samples testing positive for these pathogens were assessed for cytokine gene transcription. The pathogens were detected at the RNA level, which indicated that viable organisms were present, essential when pathogens that are known to be present in the host in different states, including the latent state are being investigated (Pusterla and others 2005) . The detection of protozoal cDNA indicated that there were viable organisms in the 12 horses with EPM. Only small numbers of protozoal stages are often present in the neural tissue of affected horses and they can be difficult to locate in routinely stained histological sections, despite the presence of inflammation (Dubey and others 2001a) . The PCR could be useful in the postmortem diagnosis of EPM in cases in which there are only small numbers of protozoal pathogens. In the 11 EHV-1-positive horses, the cDNA signals were compatible with the presence of an active replicating virus. The wide range of viral transcription levels may have been associated with differences in the stage of the disease, the strain of virus, the individual animal's immune response or whether they had been treated. The EHV-1 PCR is a useful postmortem method for detecting a viral pathogen that may be difficult to detect in neural tissue by other tests. Although the cellular tropism of S neurona, N hughesi and EHV-1 is well known, the cellular source of the pathogens remains unclear, because no in situ hybridisation was performed during the study. In two of the horses, both apicomplexan pathogens were detected. To the authors' knowledge such a dual infection has not previously been reported. The infection with N hughesi would have been missed, in the absence of detectable agent, by routine histology and by S neurona specific immunohistochemistry. Although the risk factors for exposure to the two pathogens are different (Duarte and others 2004) , exposure to both of them has been reported on the basis of the detection of specific antibodies to both in serum (Vardeleon and others 2001 ). The cytokine profile of horses infected with S neurona and/or N hughesi was characterised by the expression of IL-8, IL-10, TNF-α and IFN-γ, whereas the horses infected with EHV-1 expressed IL-8 and TNF-α. IL-8 is produced mainly by macrophages and endothelial cells and is considered to be an inflammatory mediator and a chemotactic agent primarily for neutrophils, and it is expressed as a result of tissue injury or inflammation (Sherwood and Prough 2000) . In the present study there was more transcription of in EPM-positive tissues than in EHV-1-positive tissues, possibly indicating that there may be differences in inflammatory state between the two diseases. There was also a positive correlation between IL-8 transcription and the relative levels of transcription of protozoal cDNA. This would suggest that the pathophysiology of EPM may be mediated primarily by the pathogen rather than being a dysfunctional immune response. In comparison, IL-8 secretion has been shown to be an important host-cell response to T gondii, a ubiquitous protozoan parasite causing encephalitis (Denney and others 1999 ). An increase in the secretion of in response to infection has been reported for invasive pathogens other than protozoa, including enteroinvasive bacteria, Cryptosporidium parvum and Chlamydia species (Eckmann and others 1993 , Jung and others 1995 , Laurent and others 1997 , Rasmussen and others 1997 . Protozoal parasites require a long period of intracellular development before they lyse the host cell (Denney and others 1999) . They induce minimal cytoskeletal changes in the cells of the host during their invasion and, therefore, are slow inducers of a proinflammatory cytokine response. In contrast, the rapid cytokine inducers, such as enteroinvasive pathogens, rapidly lyse and disrupt host cells (Finlay and Falkow 1988) . On the basis of its pathophysiology EHV-1 must follow the IL-8 cytokine pattern of the rapid cytokine inducers.
TNF-α and IFN-γ were commonly expressed in the neural tissue of the horses with EPM; TNF-α is produced predominantly by CD4 + T cells, whereas IFN-γ is produced in natural killer cells, CD8 + T cells and macrophages, and both cytokines have multiple, primarily proinflammatory and cell-mediated actions. The positive correlation between the relative levels of transcription of protozoal cDNA and IFN-γ provides evidence that the parasite induces a cell-mediated immunity. In vitro and in vivo studies have shown that TNF-α and IFN-γ cytokines are key mediators in triggering immune-effector functions against T gondii during both acute and chronic stages of infection others 1992a, b, Denkers and Gazzinelli 1998) . However, if uncontrolled, this T gondiiinduced cell-mediated immunity can lead to tissue damage, pathological changes, and sometimes death (Denkers and Gazzinelli 1998) . The levels of TNF-α are commonly correlated with the severity of the clinical signs and the outcome of infectious neurological diseases (Hackett and others 2001) . If TNF-α were expressed in CSF, it might be useful as a prognostic indicator in horses with EPM. The level of TNF-α was positively correlated with the level of IL-8 gene transcription in the EPM-positive tissues. Both cytokines are indicators of inflammatory pathways and have been shown to be strongly correlated with each other in a variety of infectious neurological diseases (Kornelisse and others 1996) .
High levels of IFN-γ, a strong marker of Th1 cell responses, seem to exert a protective effect against protozoal pathogens such as T gondii and S neurona (Fritz and Dubey 2002, Norose and others 2003) . S neurona-infected IFN-γ knockout mice have been shown to be immunocompromised and unable to clear the infection (Witonsky and others 2003) . The results of the present study suggest that horses with EPM are not immunocompromised and mount appropriate responses to help fight the invading pathogen. The EHV-1-positive neural tissues did not express any IFN-γ and only two tissues expressed low levels of TNF-α; IFN-γ has antiviral properties, and helps to protect neurons from destructive encephalitis during viral infections of the CNS (Lewandowski and others 1998) . Although this effect has been observed for human neurotropic herpesviruses, the direct effect of EHV-1 on neural tissue is still unclear, and ischaemic injury secondary to vasculitis appears to be the major mechanism of neuro pathology in EHV-1 infection (Osterrieder 2004) . The lack of expression of IFN-γ may play a role in the pathophysiology of EHV-1 myeloencephalopathy.
IL-10, an immunosuppressive cytokine produced mainly by Th2 cells, is a potent inhibitor of Th1 cell cytokines. The increase in both pro-and anti-inflammatory cytokines in the neural tissues of the horses with EPM suggests a generalised dysregulation of the inflammatory pathways. As has been observed in mice, the chronic stage of T gondii infection is often associated with a decrease in the levels of proinflammatory cytokines and a decrease in the level of the anti-inflammatory cytokine (Gazzinelli and others 1993) . Neural tissues from the horses with EHV-1 did not express any  this may be related to the acute nature of the disease or to the ability of EHV-1 to evade or alter the immune response of the host (Rappocciolo and others 2003) . It has been reported that herpesviruses, such as EHV-2 and Epstein-Barr virus, can harbour an IL-10-like gene in their genomes (Hsu and others 1990, Rode and others 1993) . Rode and others (1993) proposed that viral IL-10 could affect the cellular immune response by inhibiting the production of the IFN-γ cytokine.
The levels of a panel of cytokines in the brain and spinal cord tissue of horses with EPM, EHV-1 myeloencephalopathy, and healthy control horses have been compared. The cytokine profiles of each disease indicated that there was a balance between the inflammation triggered by the pathogen and the immunological reactions of the hosts. In the horses with EPM the proinflammatory Th1 cytokines (IL-8, TNF-α and IFN-γ) were commonly expressed, but the Th2 cytokines (IL-4, and IL-10) were absent or rare. In the horses with EHV-1 the proinflammatory cytokine IL-8 was commonly expressed, but IL-10 and IFN-γ were not, and TNF-α was rare. Further studies will be needed to determine whether the stage of the diseases may influence the cytokine response of neural tissues to these pathogens.
